Abstract
The fear of biological warfare agents (BWA) use by terrorists is the major concern of the security agencies and health authorities worldwide today. The non-existence of vaccines or drugs against most BWA and the possibility of genetic modified strains has turned the search for new drugs to a state of urgency. Fast in silico techniques are, therefore, perfect tools for this task once they can quickly provide structures of several new lead compounds for further experimental work. Here we try to present a mini-review on docking and molecular dynamics simulations studies applied to the drug design against the BWA Bacillus anthracis and Yersinia pestis.
Keywords: Biological warfare agents, docking studies, molecular dynamic simulations.
Current Computer-Aided Drug Design
Title:Applications of Docking and Molecular Dynamic Studies on the Search for New Drugs Against the Biological Warfare Agents Bacillus anthracis and Yersinia pestis
Volume: 9 Issue: 4
Author(s): Tanos Celmar Costa França, Ana Paula Guimarães, Wilian Augusto Cortopassi, Aline Alves Oliveira and Teodorico Castro Ramalho
Affiliation:
Keywords: Biological warfare agents, docking studies, molecular dynamic simulations.
Abstract: The fear of biological warfare agents (BWA) use by terrorists is the major concern of the security agencies and health authorities worldwide today. The non-existence of vaccines or drugs against most BWA and the possibility of genetic modified strains has turned the search for new drugs to a state of urgency. Fast in silico techniques are, therefore, perfect tools for this task once they can quickly provide structures of several new lead compounds for further experimental work. Here we try to present a mini-review on docking and molecular dynamics simulations studies applied to the drug design against the BWA Bacillus anthracis and Yersinia pestis.
Export Options
About this article
Cite this article as:
França Celmar Costa Tanos, Guimarães Paula Ana, Cortopassi Augusto Wilian, Oliveira Alves Aline and Ramalho Castro Teodorico, Applications of Docking and Molecular Dynamic Studies on the Search for New Drugs Against the Biological Warfare Agents Bacillus anthracis and Yersinia pestis, Current Computer-Aided Drug Design 2013; 9 (4) . https://dx.doi.org/10.2174/15734099113099990033
DOI https://dx.doi.org/10.2174/15734099113099990033 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Micronutrient Deficiency in Pulmonary Tuberculosis - Perspective on Hepatic
Drug Metabolism and Pharmacokinetic Variability of First-line Anti-
Tuberculosis Drugs: Special Reference to Fat-soluble Vitamins A, D, & E
and Nutri-epigenetics
Drug Metabolism Letters Disease Progression in Children with Vertically-Acquired HIV Infection in Sub-Saharan Africa: Reviewing the Need for HIV Treatment
Current HIV Research Psoriatic Arthritis – Review of the Immunologic, Clinic and Therapeutic Aspects of an Inflammatory Systemic Disease
Current Rheumatology Reviews Lactoferricin Derived From Milk Protein Lactoferrin
Current Pharmaceutical Design Spices Chemoconstituents as Persuasive Inhibitor of S. typhimurium Virulent Protein L-asparaginase
Letters in Drug Design & Discovery Hydroxypyridinone Derivatives: A Fascinating Class of Chelators with Therapeutic Applications - An Update
Current Medicinal Chemistry Recent Developments in Azole Compounds as Antitubercular Agent
Mini-Reviews in Organic Chemistry Targeting Iron Acquisition by Mycobacterium tuberculosis
Infectious Disorders - Drug Targets Recent Developments in Patents Targeting Toll-Like Receptor Genes
Recent Patents on DNA & Gene Sequences Ethnic Differences in Pharmacogenetically Relevant Genes
Current Drug Targets γ δ T Cells and Dendritic Cells: Close Partners and Biological Adjuvants for New Therapies
Current Molecular Medicine Pharmacologic Role of Vitamin D Natural Products
Current Vascular Pharmacology Anti-TNF and Crohns Disease: When Should We Stop?
Current Drug Targets Chemoinfectomics in Drug Design and Development
Anti-Infective Agents The Parent-into-F1 Model of Graft-vs-Host Disease as a Model of In Vivo T Cell Function and Immunomodulation
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Virus-Associated Vasculitides: An Update
Current Immunology Reviews (Discontinued) The Contribution of Host Genetics to TB Disease
Current Respiratory Medicine Reviews Polyphenol Supplementation as a Complementary Medicinal Approach to Treating Inflammatory Bowel Disease
Current Medicinal Chemistry Combined 3D-QSAR and molecular docking study for identification of diverse natural products as potent Pf ENR inhibitors
Current Computer-Aided Drug Design Bioactive Constituents from an Endophytic Fungus, Penicillium polonicum NFW9, Associated with Taxus fauna
Medicinal Chemistry